We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Buys

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$15M
2
EB
Eventbrite
EB
+$9.72M
3
ESTA icon
Establishment Labs
ESTA
+$9.35M
4
PRO
PROS Holdings
PRO
+$7.11M
5
PCRX icon
Pacira BioSciences
PCRX
+$6.75M

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
126
STAAR Surgical
STAA
$1.21B
$3.31M 0.19%
62,920
-10,162
-14% -$619K
PRFT
127
DELISTED
Perficient Inc
PRFT
$3.31M 0.19%
39,668
-4,752
-11% -$350K
MTRN icon
128
Materion
MTRN
$6.04B
$3.27M 0.19%
28,625
-564
-2% -$61.2K
ABCM
129
DELISTED
Abcam PLC
ABCM
$3.22M 0.18%
+131,731
New +$2.27M
ONT
130
Onterris Inc
ONT
$580M
$3.22M 0.18%
76,432
-9,422
-11% -$339K
COLB icon
131
Columbia Banking Systems
COLB
$8.84B
$3.16M 0.18%
155,833
-24,271
-13% -$513K
PNTG icon
132
Pennant Group
PNTG
$1.36B
$3.09M 0.18%
251,663
-23,722
-9% -$302K
IRMD icon
133
iRadimed
IRMD
$1.18B
$3.08M 0.17%
64,546
-7,725
-11% -$348K
EXPO icon
134
Exponent
EXPO
$3.24B
$3.05M 0.17%
32,656
-3,867
-11% -$364K
LUCK
135
Lucky Strike Entertainment
LUCK
$911M
$3.04M 0.17%
261,184
-45
-0% -$600
ALNT icon
136
Allient
ALNT
$1.92B
$3M 0.17%
75,092
-36,520
-33% -$1.33M
HURN icon
137
Huron Consulting
HURN
$2.42B
$2.97M 0.17%
34,939
-4,249
-11% -$348K
CRAI icon
138
CRA International
CRAI
$1.06B
$2.97M 0.17%
29,074
-3,620
-11% -$365K
PLOW icon
139
Douglas Dynamics
PLOW
$1.02B
$2.95M 0.17%
98,853
-12,163
-11% -$357K
WKME
140
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$2.88M 0.16%
300,438
+24,144
+9% +$234K
MNRO icon
141
Monro
MNRO
$398M
$2.88M 0.16%
70,912
-648
-0.9% -$29.2K
EHC icon
142
Encompass Health
EHC
$12.4B
$2.85M 0.16%
42,146
-237
-0.6% -$14.9K
BMRN icon
143
BioMarin Pharmaceuticals
BMRN
$12.4B
$2.83M 0.16%
32,685
-1,354
-4% -$127K
NEOG icon
144
Neogen
NEOG
$2.5B
$2.82M 0.16%
129,783
-28,969
-18% -$524K
MYRG icon
145
MYR Group
MYRG
$5.25B
$2.79M 0.16%
20,189
-11,571
-36% -$1.51M
TFX icon
146
Teleflex
TFX
$5.98B
$2.78M 0.16%
11,480
-476
-4% -$119K
ETSY icon
147
Etsy
ETSY
$7.85B
$2.7M 0.15%
31,954
-1,284
-4% -$121K
ICLR icon
148
Icon
ICLR
$12.7B
$2.68M 0.15%
10,710
-3,436
-24% -$730K
RYTM icon
149
Rhythm Pharmaceuticals
RYTM
$7.96B
$2.62M 0.15%
158,959
+5,173
+3% +$93.4K
FOXF icon
150
Fox Factory Holding Corp
FOXF
$886M
$2.6M 0.15%
23,950
-5,297
-18% -$542K
4 5
6
7 8

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.